University of Rochester
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Rochester sits in the top decile of US sponsors by registered trial count (#53 of 15,742 sponsors by registered trial count).
University of Rochester: 636 sponsored US clinical trials, 94 recruiting.
University of Rochester sponsors 636 registered US clinical trials on ClinicalTrials.gov, 94 of them currently recruiting, and 448 completed. 54 of these trials are in Phase 3-4 (later-stage) and 147 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cancer, with 7 trials.
Top-decile sponsor footprint
University of Rochester ranks in the top decile of sponsors by registered trial count (#53 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
448 of 506 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
636 total, page 6 of 13
ASPIRE: PROs & Caregiver Burden in Children With Atopic Dermatitis
NCT03645057
A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic Syndromes
NCT03746041
Duration of Effect of Biotene Spray in Patients With Dry Mouth
NCT03663231
Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors
NCT03771157
A Study of a Mastoid Device in Subjects With Ménière's Disease
NCT03520322
Acceptability of Palliative Care in Parkinson Disease Care
NCT03697434
Telemedicine Enhanced Asthma Management - Uniting Providers
NCT03545906
Custom Anterior Surfacing of Scleral Lens for Vision Quality Improvement in Patients With Keratoconus
NCT03647046
Cisplatin in Castration Resistant Prostate Cancer
NCT03275857
Cardiac Surgery Peer Recovery Support Program
NCT03590106
Mobile Cessation Support for Latino Smokers
NCT03586596
Measuring the Peripheral Optical Quality of The Eye
NCT03479827
A Study of Parent and Child Emotions in Fetal Alcohol Spectrum Disorder (FASD)
NCT03524664
Efficacy of IV Acetaminophen Versus Oral Acetaminophen
NCT03365622
Scratch and Sleep Quantification in Atopic Dermatitis
NCT03490877
A Whole-food, Plant-Based Nutrition Intervention in Women With Metastatic Breast Cancer
NCT03045289
Promoting Cervical Cancer Screening for Emergency Department Patients
NCT03483610
Promoting Partnership and Improving Self-Management for Children With Persistent Asthma
NCT03390556
Studying Infant Nutrition and Blood Sugar
NCT03524469
Remediation of Visual Perceptual Impairments in People With Schizophrenia
NCT03314129
Feasibility of Enhanced Dialysis Education (EDU) Intervention for Chronic Kidney Disease (CKD) Patients
NCT03465449
Video-based Detection of Atrial Fibrillation
NCT04267133
Smartphone Utilization for Glucose Monitoring and Antenatal Reporting
NCT03504592
Brain Effects of Opiate Agonist and Antagonist
NCT04342130
Aromatherapy for Integrated Cancer Care
NCT03449511
Simulated Rehearsal for Percutaneous Nephrolithotomy
NCT03272529
Visual Restoration for Hemianopia
NCT03350919
Brief New Treatment for Suicide Attempts
NCT03300596
Reducing Up-set Stomach and Vomiting After Surgery Using Essential Oils
NCT03370328
Technology Enabled Asthma Management System (TEAMS) Pilot Study
NCT03648203
Brief Intervention for Justice-Involved Substance Users
NCT03308877
The Helping Older People Engage Project: Improving Social Well-Being in Later Life
NCT03343483
Eye Movements, Visual Perception and Attention
NCT03884985
Study of Testosterone and rHGH in FSHD
NCT03123913
Evaluation of the School Kids Influenza Prevention Project
NCT03307642
Digital vs Conventional Impressions Study
NCT03146780
Simulated Surgery Rehearsal (MIPN)
NCT03155295
HARP-Project 1 Cognitive Training
NCT03293823
Career Enhancement Training Study (USAF)
NCT04067401
Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment
NCT03292705
Steroid Delivery to the Frontal Sinus Opening With a Bioabsorbable Implant vs. a Bioabsorbable Nasal Dressing
NCT03188822
Development and Pilot Testing of the Students With Autism Accessing General Education (SAAGE) Model
NCT03573128
Utility of Pharmacogenomic Testing and Postoperative Dental Pain Outcomes
NCT02932579
Exercise and Nutrition Interventions During Chemotherapy
NCT03021174
Realizing Opportunities for Self-Supported Improvement (ROSSI)
NCT03016481
Deaf Weight Wise 2.0: A Healthy Lifestyle Intervention With Deaf Adults Who Are Overweight or Obese
NCT03060525
Women's Initiative Supporting Health Increasing Healthcare Access
NCT02964845
DC-STAMP: Regulators of Osteoclastogenesis and Response Marker in PsA
NCT03011242
Telemedicine Enhanced Asthma Management Through the Emergency Department
NCT02752165
Junctional AV Ablation in CRT-D: JAVA-CRT
NCT02946853
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 66 |
| Phase 2 | 81 |
| Phase 3 | 20 |
| Phase 4 | 34 |
Therapeutic Areas
What is open in the University of Rochester pipeline
94 recruiting of 636 indexed (15% open); 448 completed (70%).
Phase mix: 54 late (III/IV) vs 147 early (I/II) (early-phase heavy).
Top condition: Cancer (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Rochester: open-pipeline peers nationwide
Peers matched on 636 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Rochester sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 636 trials (± recruiting share)
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Southern California · 617 trials · 16% recruiting
- Baylor College of Medicine · 616 trials · 15% recruiting
- University of California, Davis · 657 trials · 19% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Loma Linda University · 15% recruiting · 237 trials
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Brown University · 15% recruiting · 231 trials
Related
What to do with this University of Rochester page
636 registered trials is a research-attention snapshot, not an endorsement of University of Rochester or any single study.
- 94 of University of Rochester's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cancer is the condition University of Rochester studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Rochester pipeline card: 636 registered trials from official public datasets.Report a data error.